Cerus Corp (CERS)

2.26
0.01 0.44
NASDAQ : Health Care
Prev Close 2.25
Open 2.32
Day Low/High 2.19 / 2.33
52 Wk Low/High 4.27 / 6.89
Volume 4.38M
Avg Volume 1.00M
Exchange NASDAQ
Shares Outstanding 103.94M
Market Cap 311.82M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

First Patient Transfused In Cerus' Phase III RedeS Study Evaluating Safety And Efficacy Of The INTERCEPT Red Blood Cell System

First Patient Transfused In Cerus' Phase III RedeS Study Evaluating Safety And Efficacy Of The INTERCEPT Red Blood Cell System

Cerus Corporation (NASDAQ: CERS) announced today that the first patient has been transfused in Puerto Rico for the "INTERCEPT Blood System for Red Blood Cells in Regions at Potential Risk for Zika Virus...

Cerus Announces Exercise Of Additional BARDA Contract Options Totaling $46.6 Million To Support INTERCEPT Red Blood Cell System Development

Cerus Announces Exercise Of Additional BARDA Contract Options Totaling $46.6 Million To Support INTERCEPT Red Blood Cell System Development

Cerus Corporation (NASDAQ: CERS) announced today that additional options totaling $46.

Notable Thursday Option Activity: CERS, BZH, CATM

Notable Thursday Option Activity: CERS, BZH, CATM

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Cerus Corp. , where a total volume of 3,279 contracts has been traded thus far today, a contract volume which is representative of approximately 327,900 underlying shares (given that every 1 contract represents 100 underlying shares).

Cerus Corporation Reports First Quarter 2017 Results

Cerus Corporation Reports First Quarter 2017 Results

Cerus Corporation (NASDAQ: CERS) today announced financial results for the first quarter ended March 31, 2017.

Cerus To Release First Quarter 2017 Results On May 3, 2017

Cerus To Release First Quarter 2017 Results On May 3, 2017

Cerus Corporation (NASDAQ:CERS) announced today that its first quarter results will be released on Wednesday, May 3, 2017, after the close of the stock market.

Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cerus Corporation (NASDAQ:CERS) announced today that, on April 3, 2017, the compensation committee of the company's board of directors granted 21 new non-executive employees options to purchase an aggregate of...

First Week of CERS November 17th Options Trading

First Week of CERS November 17th Options Trading

Investors in Cerus Corp. saw new options become available this week, for the November 17th expiration.

Cerus Corporation Reports Fourth Quarter And Year End 2016 Results

Cerus Corporation Reports Fourth Quarter And Year End 2016 Results

Cerus Corporation (NASDAQ:CERS) today announced financial results for the fourth quarter and year ended December 31, 2016.

Cerus To Present At The Cowen And Company 37th Annual Health Care Conference On March 8, 2017

Cerus To Present At The Cowen And Company 37th Annual Health Care Conference On March 8, 2017

Cerus Corporation (NASDAQ:CERS) announced today that William "Obi" Greenman, president and chief executive officer, is scheduled to present a corporate update at the Cowen and Company 37th Annual Health Care Conference at...

First Week of April 21st Options Trading For Cerus Corp.

First Week of April 21st Options Trading For Cerus Corp.

Investors in Cerus Corp. saw new options become available this week, for the April 21st expiration.

Cerus To Release Fourth Quarter And Year End 2016 Results On March 7, 2017

Cerus To Release Fourth Quarter And Year End 2016 Results On March 7, 2017

Cerus Corporation (NASDAQ:CERS) announced today that its fourth quarter and year end results for 2016 will be released on Tuesday, March 7, 2017, after the close of the stock market.

Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cerus Corporation (NASDAQ: CERS) announced today that, on January 3, 2017, the compensation committee of the company's board of directors granted fifteen new non-executive employees options to purchase an...

Relative Strength Alert For Cerus

Relative Strength Alert For Cerus

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

First Week of August 2017 Options Trading For Cerus (CERS)

First Week of August 2017 Options Trading For Cerus (CERS)

Investors in Cerus Corp. saw new options become available this week, for the August 2017 expiration.

Cerus Announces Exercise Of Additional BARDA Contract Options Totaling $10,825,555 For Activities Related To Its Planned Phase III Trial Of The INTERCEPT Red Blood Cell System

Cerus Announces Exercise Of Additional BARDA Contract Options Totaling $10,825,555 For Activities Related To Its Planned Phase III Trial Of The INTERCEPT Red Blood Cell System

Cerus Corporation (NASDAQ: CERS) announced today that additional options totaling $10,825,555 have been exercised under its contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the U.

Cerus Provides An Update On The Timeline For The INTERCEPT Blood System For Red Blood Cells In Europe

Cerus Provides An Update On The Timeline For The INTERCEPT Blood System For Red Blood Cells In Europe

Cerus Corporation (NASDAQ:CERS) today provided an update on the timeline for the INTERCEPT Blood System for Red Blood Cells (RBCs) in Europe.

January 2017 Options Now Available For Cerus (CERS)

January 2017 Options Now Available For Cerus (CERS)

Investors in Cerus Corp. saw new options begin trading today, for the January 2017 expiration.

Cerus (CERS) Stock Surges on Q3 Results, Outlook

Cerus (CERS) Stock Surges on Q3 Results, Outlook

Cerus (CERS) reported a narrower-than-expected loss for the 2016 third quarter after yesterday's market close.

Cerus Corporation Reports Third Quarter 2016 Results

Cerus Corporation Reports Third Quarter 2016 Results

Cerus Corporation (NASDAQ: CERS) today announced financial results for the third quarter ended September 30, 2016.

Cerus To Present At The Stephens 2016 Fall Investment Conference On November 8, 2016

Cerus To Present At The Stephens 2016 Fall Investment Conference On November 8, 2016

Cerus Corporation (NASDAQ:CERS) announced today that Kevin Green, Cerus' vice president, finance and chief financial officer, is scheduled to present a corporate update at the Stephens 2016 Fall Investment Conference at...

First Week of December 16th Options Trading For Cerus (CERS)

First Week of December 16th Options Trading For Cerus (CERS)

Investors in Cerus Corp. saw new options become available this week, for the December 16th expiration.

Cerus To Release Third Quarter 2016 Results On November 3, 2016

Cerus To Release Third Quarter 2016 Results On November 3, 2016

Cerus Corporation (NASDAQ:CERS) announced today that its third quarter results will be released on Thursday, November 3, 2016, after the close of the stock market.

Relative Strength Alert For Cerus

Relative Strength Alert For Cerus

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cerus Announces First U.S. Blood Center Customer Submits Biologics License Application To The FDA To Allow For Interstate Export Of INTERCEPT Platelet Components

Cerus Announces First U.S. Blood Center Customer Submits Biologics License Application To The FDA To Allow For Interstate Export Of INTERCEPT Platelet Components

Cerus Corporation (NASDAQ:CERS) announced today that The Community Blood Center (CBC) of Appleton, Wisconsin has submitted the first Biologics License Application (BLA) to the U.

Cerus Announces That Hemolife Fundación Banco Nacional De Sangre Has Entered Into Routine Use Of The INTERCEPT Blood System

Cerus Announces That Hemolife Fundación Banco Nacional De Sangre Has Entered Into Routine Use Of The INTERCEPT Blood System

Cerus Corporation (NASDAQ:CERS), a biomedical products company focused in the field of blood transfusion safety, announced today that Hemolife Fundación Banco Nacional de Sangre (Hemolife) is now offering...

Cerus (CERS) Shares Cross Below 200 DMA

Cerus (CERS) Shares Cross Below 200 DMA

In trading on Thursday, shares of Cerus Corp. crossed below their 200 day moving average of $6.03, changing hands as low as $5.99 per share.

Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cerus Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Cerus Corporation (NASDAQ:CERS) announced today announced that, on October 1, 2016, the compensation committee of the company's board of directors granted ten new non-executive employees options to purchase an...

First Week of May 2017 Options Trading For Cerus (CERS)

First Week of May 2017 Options Trading For Cerus (CERS)

Investors in Cerus Corp. saw new options begin trading this week, for the May 2017 expiration.